Sage Journals: Discover world-class research

Abstract

Psoriasis is a complex chronic inflammatory skin disease characterized by epidermal thickening on the basis of increased keratinocyte proliferation and insufficient apoptosis. Laminins are important components of the basement membrane (BM) and impact on epidermal keratinocyte growth/apoptosis. Although several laminins are involved in the pathogenesis of psoriasis, it is still controversial about the expression patterns of laminin isoforms and which laminins are important in the development of psoriasis. Because laminin-511 and -332 are key BM components in human skin, and laminin-511 stimulates human hair follicle growth, we asked whether the BM zone in psoriasis shows any laminin-related abnormalities. This showed that the BM expression of laminin-511 and -332 was significantly increased within the skin lesion of psoriasis. Immunofluorescence microscopy revealed that laminin-511, -332, and collagen type IV proteins were also significantly increased in psoriasis-like skin lesions of Imiquimod-treated mice. Transmission electron microscopy showed a few gaps of lamina densa, and its thickness was significantly increased. Finally, laminin-511 treatment significantly stimulated the proliferation and inhibited apoptosis of HaCaT cells, while laminin-α5 chain gene knockdown decreased proliferation and induced apoptosis. These phenomenological observations raise the question of whether laminin-511-controlled keratinocyte growth/death may be a previously overlooked player in the pathogenesis of psoriatic epidermal lesions.

Keywords

basement membrane keratinocyte laminin-511 psoriasis

Introduction

Psoriasis is a chronic inflammatory skin disease that is characterized by hyperproliferation of keratinocytes (KC), along with insufficient KC apoptosis^1,2 and hyperkeratosis.³

As a treatment, topical therapies including glucocorticosteroids, vitamin D derivatives, and calcineurin inhibitors, a systemic therapy by cyclosporin, methotrexate, or retinoic acid derivatives, and phototherapies are used. Although several effective antipsoriatic drugs including biologicals have been developed, severe psoriasis remains a major therapeutic challenge, and novel treatment strategies that go beyond the mainstream intervention principles of current biologicals^4–6 are most postulated.

Here, we explore the working hypothesis that the basement membrane (BM) zone, which divides epidermis and dermis, deserves greater attention in psoriasis pathobiology and possibly psoriasis management than it has been considered so far.

The BM is composed of extracellular matrix (ECM) proteins, including various types of collagen, elastin, fibronectin, laminin, fibrin, perlecan, entactin, and nidogen.^7–11 These ECM proteins interact with different cell types, particularly epidermal cells, fibroblasts, and inflammatory cells¹² to regulate cell proliferation, cell differentiation, cell motility, and apoptosis.^13,14

However, the role of ECM proteins in the development of psoriatic epidermal lesions remains to be fully investigated.^15–17 Notably, however, McFadden et al. have proposed a laminin-dependent mechanism by which self-limiting guttate psoriasis caused by streptococcal pharyngitis develops to chronic psoriasis. Briefly, streptokinase, which is produced by streptococci, can initiate lysis and disruption of laminin.^18–20 This may then promote KC instability and proliferative tendency via inducing the interaction of fibronectin with α5β1 integrin.^18–20 To support this hypothesis, other studies have also reported that the disruption of laminin can be detected in psoriasis skin. Mondello et al. reported that the expression of laminin-1 (composed of α1, β1, and γ1 chains) was discontinuous and fragmented in uninvolved psoriatic skin.²¹ Vaccaro et al. reported that laminin α1 chain expression was discontinuous both in involved and uninvolved psoriatic skin, while the expression of fibronectin was overexpressed in the papillary dermis.²² Toti et al. found that laminin α2 chain expression was weak and irregular in psoriatic skin lesion.²³ However, in contrast to the observations by others,^21,22 they also reported that laminin α1, β1, and γ1 chains expression were normal.²³ Fleischmajer et al. reported that the expression of laminin α2, α5, β1, and γ1 chains were reduced in the involved area of psoriasis.¹⁵

Because the psoriatic epidermal lesion and active hair growth (anagen development) share a number of intriguing, yet underappreciated, common features,²⁴ it is interesting to note that laminins play an important role in hair follicle (HF) biology.^25–29 We have previously shown that laminin-332, which is composed of α3, β3, and γ2 chains, and laminin-511 composed of α5, β1, and γ1 chains represent key laminins in human skin.⁹ These laminins play important roles as regulators of KC migration in wound healing and tumorigenesis and modulate skin appendage development.⁹ During the hair cycle, laminin-332 and its binding partner, α6β4 integrin, are not expressed along the BM of the HFs during the anagen and then expressed from midcatagen to telogen.^28,29 In line with this, the number of hemidesmosomes is decreased along the BM of the lower HF at late anagen.²⁸ In contrast, laminin-511 and its binding partner α3β1 integrin are stably expressed along the BM of the whole HF during the hair cycle.^28,29 Finally, we have shown by using the normal human HF organ culture system that laminin-511 stimulated human HF growth, while laminin-332 inhibited it.^28,30 Thus, laminin-511 operates largely as a hair growth stimulator, while laminin-332 appears to work as a brake on HF growth by increasing the number of hemidesmosomes.^9,28–30

Therefore, we hypothesized that similar differential effects of laminins on epidermal KC proliferation may also play a role during the development of the psoriatic epidermal lesion,^2,31 and have asked in the current study whether laminin-332 and -511 expression is abnormal in the BM zone of psoriatic skin lesions, and whether laminin-511 has an impact on KC proliferation and apoptosis.

Materials and Methods

Antibodies

In mice samples, a rabbit polyclonal antiserum termed J18 generated against all three subunits of laminin-332, a rabbit polyclonal antibody against mouse recombinant laminin-α5, a rat monoclonal antibody against mouse laminin-β1 (LT3, ab44941; Abcam; Cambridge, UK), a rat monoclonal antibody against mouse laminin-γ1 (SPM277, ab17792; Abcam), a rat monoclonal antibody against mouse β1 integrin (MB1.2, MAB1997; Merk, Millipore; Darmstadt, Germany), a rat monoclonal antibody against mouse β4 integrin (BD Biosciences; Franklin Lakes, NJ), a rabbit polyclonal antibody against mouse fibronectin (ab2413; Abcam), and a rabbit polyclonal antibody against type IV collagen (ab6586; Abcam) were used.

In human samples, a rabbit polyclonal antibody against human laminin-5 (ab14509; Abcam) and a mouse monoclonal antibody against human laminin-α5 (4B12, MABT39; Merk, Millipore), and a rat monoclonal antibody against human laminin-γ1 (ab17792; Abcam) were used.

For HaCaT cells, a mouse monoclonal antibody against human laminin-α5 (Merk, Millipore), a mouse monoclonal antibody against Ki-67 (MIB-1, M7240; Dako; Santa Clara, CA), and a rabbit polyclonal antibody against cleaved caspase-3 (D175; Cell Signaling Technology; Danvers, CO) were used.

Goat anti-rabbit IgG Alexa Fluor 594, goat anti-rat IgG Alexa Fluor 568, goat anti-rabbit IgG Alexa Fluor 488, and goat anti-mouse IgG Alexa Fluor 488 were obtained from Molecular Probes (Eugene, OR). FITC-conjugated goat anti-rabbit IgG was obtained from Zymed Laboratories Inc. (South San Francisco, CA). FITC-conjugated goat anti-mouse IgG was obtained from CHEMICON (Tokyo, Japan).

Mice and Treatment

We used 8-week-old C57BL/6 mice to induce psoriasiform skin lesions by topical Imiquimod application as previously described.^32–34 Mice were purchased from Japan SLC Inc., and provided with food and water ad libitum.

All experiments were approved by the animal ethics committee.

Mice at 8 weeks of age received a daily topical dose of 62.5 mg of commercially available Imiquimod (IMQ) cream (5%; Mochida Pharmaceutical Co., Ltd.; Tokyo, Japan) on the shaved back for 5 consecutive days, translating to a daily dose of 3.125 mg of the active compound. This dose was empirically determined to cause most optimal and reproducible skin inflammation in mice (data not shown).

We obtained back skin specimens of the mice that received IMQ cream just after the termination of drug application (on day 6, after 5 consecutive days of treatment).

Control mice were treated similarly with a control vehicle cream (Vaseline Lanette cream; Kenei Pharmaceutical Co., Ltd.; Osaka, Japan).

Human Samples

Human normal skin samples were obtained from peripheral skin after the benign skin tumorectomy. The number of normal human skin samples is 5 (aged 64–81 years; average, 72.6 years). The parts of the resected benign tumors are abdomen (two subjects), lower limb (two subjects), and head (one subject).

Human skin samples of psoriasis were obtained from Kochi University and Nagoya City University. The number of human skin samples of psoriasis is 5 (aged 34–63 years; average, 50.4 years). We evaluated the stage of psoriatic lesion of human skin samples by H&E histochemistry. All of them showed “absence of spongiosis,” “parakeratosis with neutrophils collections,” “decreased granular zone within the epidermis,” and “psoriasiform hyperplasia with rete ridges.” Therefore, we considered skin samples that we obtained for this study as the “fully developed” stage.

Human tissue collection and handling were performed according to Declaration of Helsinki guidelines, with institutional research ethics committee approval (Osaka City University, Kochi University, and Nagoya City University), and written informed consent was obtained from the patients.

Histopathology and Immunohistochemistry (IHC)

For histochemical examination, skin specimens of mice were fixed in 4% paraformaldehyde in PBS, dehydrated, and embedded in paraffin. Sections of 4-µm thickness were cut and stained with H&E.

For IHC, fresh skin specimens of mice were embedded in physiological saline and frozen in liquid nitrogen. Samples from the back were immersed in TissueTek (Sakura Finetek; Japan), snap-frozen in liquid nitrogen, and stored at −80C until use. Cryosections of 4 µm of snap-frozen skin were cut using a cryostat.

For laminin-332 and β4 integrin staining, tissue sections were treated with 1% Triton X-100 in PBS for 10 min and then fixed in 2% formaldehyde in PBS for 20 min at room temperature. For laminin-α5, -β1, -γ1, and fibronectin staining, tissue sections were treated with 1% Triton X-100 in PBS for 10 min and fixed in acetone at 4C for 2 min. For β1 integrin and Ki67 staining, tissue sections were fixed in 3.7% formaldehyde in PBS for 5 min and treated with 1% Triton X-100 in PBS for 10 min. Sections were washed in PBS, and incubated overnight at 4C with primary Abs against laminin-α5, -β1, -γ1, -332, β4 integrin, β1 integrin, fibronectin, and Ki-67. Secondary antibodies in PBS at room temperature were then added for 45 min. The following secondary antibodies were used: goat-anti rabbit IgG Alexa Fluor 594 for laminin-α5 and fibronectin and Ki-67, and goat-anti rat IgG Alexa Fluor 568 for laminin-β1, γ1, and β1 integrin, and FITC-conjugated goat-anti rabbit IgG for laminin-332 and β4 integrin. Sections were washed in PBS, mounted, and examined by fluorescence microscope (BZ-8000; KEYENCE; Osaka, Japan).

For IHC, fresh-skin specimens of human and mouse back skin were immersed in TissueTek (Sakura Finetek; Japan), snap-frozen in liquid nitrogen, and stored at −80C until use. Cryosections of 5 µm of snap-frozen skin were cut using a cryostat. We used 5-µm cryosections for human skin samples, while 4-µm cryosections were used for mouse skin samples. For laminin-332, α5, and -γ1 staining, tissue sections were treated with 1% Triton X-100 in PBS for 10 min and fixed in acetone at 4C for 2 min. Sections were washed in PBS, and incubated overnight at 4C with primary Abs against laminin-332, α5, and -γ1. The following secondary antibodies were used: goat-anti rabbit IgG Alexa Fluor 488 for laminin-332, goat anti-mouse IgG Alexa Fluor 488 for laminin-α5, FITC-conjugated goat anti-rabbit IgG for laminin-γ1. Sections were washed in PBS, and treated with 4′,6-diamidino-2-phenylindole (DAPI) for 1 min. They were washed in PBS, mounted, and examined by fluorescence microscope. Normal human or murine skin samples were used as positive controls for laminin-α5, -β1, -γ1, -332, β4 integrin, β1 integrin, fibronectin, Ki-67, and cleaved caspase-3 immunofluorescence. Immunofluorescence without primary antibodies was used as negative controls.

Transmission Electron Microscopy (TEM)

Skin specimens were fixed in 0.1 M cacodylate buffer containing 2.5% glutaraldehyde and 2% paraformaldehyde and were then immersed in 1% osmium tetroxide in the same buffer. The tissue was dehydrated in a gradient series of ethanol, immersed in propylene oxide, and embedded in plastic resin. Thin and thick sections were generated on a Leica Ultracut UCT (Leica; Wetzlar, Germany). Thin sections were stained with uranyl acetate and lead citrate and observed with an electron microscope (H-7500; HITACHI; Tokyo, Japan). To evaluate the number of hemidesmosomes, we counted the number of hemidesmosomes and measured the length of lamina densa per each visual field. Then, we calculated the density of hemidesmosomes (the number of hemidesmosomes per 1 nm of lamina densa). For evaluating the thickness of lamina densa, we measured its thickness at 5 points per one image by using ImageJ software v1.49 (National Institutes of Health). At least 5 images per 1 mouse were used for the evaluation.

HaCaT Cells Culture and IHC

We performed HaCaT cells culture with vehicle and laminin-511 (at 0.1 μg/ml and 1 μg/ml, 24 hr) to evaluate their proliferation/apoptosis. In addition, we performed laminin-α5 gene knockdown in HaCaT cells using siRNA. Transfection duration was 6 hr and then cultured with normal supplemented medium for 15 hr. Laminin-511 was obtained from BioLamina (Sundbyberg, Sweden), and laminin-α5 siRNA was obtained from Santa Cruz Biotechnology (Dallas, TX).

For laminin-α5, Ki-67, and cleaved caspase-3 staining by immunohistochemical examination, tissue sections were treated with 4% paraformaldehyde in PBS for 5 min. Sections were washed in PBS, and incubated overnight at 4C with primary Abs against laminin-α5, Ki-67, and cleaved caspase-3. Secondary antibodies in PBS at room temperature were then added for 45 min. The following secondary antibodies were used: FITC-conjugated goat anti-mouse IgG for laminin-α5 and Ki-67, FITC-conjugated goat anti-rabbit IgG for cleaved caspase-3. Sections were washed in PBS, and treated with DAPI for 1 min. They were washed in PBS, mounted, and examined by fluorescence microscope.

HaCaT cells were cultured in DMEM supplemented with Penicillin streptomycin and FBS.

Measuring Fluorescence Intensity by Using NIH ImageJ

We used NIH ImageJ software for measuring fluorescence intensity of laminin-α5, β1, γ1, and laminin-332, β4 and β1 integrins, and fibronectin. Mean fluorescence intensity value within the basal membrane or dermis (for fibronectin) was measured per each image. At least 10 images were evaluated per each immunofluorescence study.

Statistical Analysis

Data were analyzed by using either the Mann-Whitney U test for unpaired samples or Dunn’s multiple comparison test by using Prism 6.0 software (GraphPad Prism; GraphPad Software; San Diego, Calif). Regarded as significant were p values of less than 0.05. All data in the figures are expressed as mean ± standard error of the mean (SEM).

Results

The Expression of Laminin-332 and -511 Is Significantly Upregulated in Psoriatic Lesions

First, we investigated the expression of main laminins within human skin, namely, laminin-332 (composed of α3, β3, and γ2 chains) and -511 (composed of α5, β1, and γ1 chains)^9,11 of lesional area of psoriasis vulgaris. Immunofluorescence microscopy using antibodies against laminin-332, laminin-α5, and γ1 chains showed that the expression of all laminin components was increased in psoriatic lesions compared with healthy control skin (Fig. 1A).

Figure 1.

The expression of both laminin-511 and -332 is significantly increased in psoriasis in human. (A) Laminin-α5, γ1, and laminin-332 immunofluorescence of skin samples from both healthy individuals and patients with psoriasis vulgaris. The arrow indicates BM. (B) The expression of laminin-α5, γ1 chains, and laminin-332 of the BM was significantly increased in skin lesions of psoriasis compared with healthy individuals. Immunofluorescence intensity was measured by NIH ImageJ. (Mean ± SEM, n=5, ***p<0.001. Scale bar = 50 μm.) Abbreviations: BM, basement membrane; NIH, National Institutes of Health; SEM = standard error of the mean.

When the immunofluorescence intensity of laminin-332 and the components of laminin-511 within the skin specimens from the patients of psoriasis were quantitated by using NIH ImageJ, the expression of both laminin-332 and the components of laminin-511 of the BM were significantly increased in psoriatic lesions (Fig. 1B). In stark contrast to the previous findings,^15,21 our quantitative data obtained from immunofluorescence study shows that main laminins along the BM within the skin, namely, laminin-332 and -511, were highly expressed in psoriatic lesional skin.

The Expression of Laminin-332 and -511 Is Also Upregulated Within the Lesional Skin of Psoriasis in Mice

Next, we wished to clarify whether similar laminin-expression abnormalities can also be seen in experimentally induced psoriatic skin lesions in a widely used mouse model of psoriasis-like dermatitis.^32–34 As expected, C57BL/6 mice that had received IMQ cream on their shaved back skin for 5 consecutive days developed psoriasis-like skin lesions,³⁴ along with epidermal thickening, parakeratosis with neutrophils, and absence of a granular layer (Fig. 2A). Because the major laminin-binding integrins consist of β1 or β4 integrins,^9,11,35 and fibronectin was reported to be involved in the development of psoriasis,^18,36–38 we examined these lesions by IHC using antibodies against the main BM components, including laminin-α5, β1, γ1, laminin-332, β1 integrin, β4 integrin, and fibronectin. Similar to the findings obtained from human skin samples, we found that, compared with vehicle-treated skin, the expression of laminin-α5, β1, and γ1 chains of psoriasis-like skin lesions was significantly increased along the BM (Fig. 2B–D). β1 integrin expression was also significantly upregulated along the BM as well as on the basolateral surface of basal layer epidermal KCs (Fig. 3A). In addition, laminin-332 and β4 integrin was also significantly increased along the BM in psoriasis-like skin (Fig. 3B and C).

Figure 2.

Laminin-511 expression is upregulated in psoriatic skin lesion in mice. (A) C57BL/6 mice, which received IMQ cream on the shaved back for 5 consecutive days, showed psoriasis-like skin. This model mouse showed epidermal thickening, parakeratosis with neutrophils, and absence of a granular layer. (H&E, original magnification ×100.) Immunofluorescence study of both normal and psoriatic skin samples. Compared with vehicle treated skin, the expression of laminin-α5 (B), β1 (C), and γ1 chains (D) of psoriasis-like skin lesions was significantly increased along the BM. The arrow indicates BM. (Mean ± SEM, n=5, **p<0.01. ***p<0.001.) (Scale bar A = 100 μm; scale bars B–D = 50 μm.) Abbreviations: IMQ, Imiquimod; BM, basement membrane; NIH, National Institutes of Health; SEM = standard error of the mean.

Figure 3.

The expression of other BM components is also upregulated in psoriasis model mice. Immunofluorescence study of normal and psoriatic skin sections in mice. Compared with vehicle treated skin, β1 integrin expression was also significantly upregulated along the BM as well as basolateral surface of basal keratinocytes (A). The expression of laminin-332 and β4 integrin was also significantly increased along the BM in psoriasis-like skin (B, C). Fibronectin was significantly upregulated within the dermis of these mice (D). The arrow indicates BM, while yellow arrows in (D) indicate fibronectin positive immunoreactivity. (Mean ± SEM, n=5, ***p<0.001. Scale bars = 50 μm.) Abbreviations: BM, basement membrane; NIH, National Institutes of Health; SEM = standard error of the mean.

Furthermore, as previously reported in human,²² fibronectin was also significantly upregulated within the dermis of these mice (Fig. 3D), and the positive immunoreactivity seemed to be detected predominantly in the papillary dermis. In line with the observations obtained by human psoriatic skin samples (Fig. 1A and B), the expression of both laminin-332 and -511 as well as their binding partners, integrin β1 and β4, were significantly increased in psoriatic lesions of the mouse model of psoriasis-like dermatitis. McFadden et al. have previously proposed a laminin-dependent mechanism by which self-limiting guttate psoriasis caused by streptococcal pharyngitis develops to chronic psoriasis. Streptokinase, which is produced by streptococci, can initiate lysis and disruption of laminin. Next, to investigate whether the disruption of laminin-511 and -332 is induced during the early period of psoriasis, we evaluated the expression of laminin-α5 and γ1 chains as well as laminin-332 of the IMQ-treated mice after the drug application for 1 or 2 consecutive days. As a result, the disruption of laminin-α5 and γ1 chains as well as laminin-332 was not detected (Fig. 4).

Figure 4.

The disruption of laminin-α5, γ1 chains, and laminin-332 is not detected during the early phase of psoriasis. The disruption of laminin-α5 and γ1 chains as well as laminin-332 of the Imiquimod-treated mice after the drug application for 1 or 2 consecutive days was not detected. (Scale bars = 50 μm.)

Ultrastructural Evaluation by TEM

Fleischmajer et al. reported that the lamina densa showed gaps, splitting, or reduplication in involved skin of psoriasis in human.¹⁵ In addition, both laminin-332 and β4 integrin are crucial components of hemidesmosomes.^{9,11,12,28,39} We next investigated the ultrastructure of BM of the mouse model of psoriasis-like dermatitis.

TEM showed that the number of hemidesmosomes was not affected in psoriasis-like skin lesions compared with vehicle control (Fig. 5A and B). However, the thickness of lamina densa was significantly increased in psoriatic lesions (Fig. 5A and B). In addition, we could detect a few gaps of lamina densa in psoriasis-like skin lesions (Fig. 5C). Interestingly, there are abundant reticular, string-like structures attached to lamina densa of psoriatic lesions (Fig. 5A). When we carefully investigated fibroblasts, numerous string-like structures attached to dermal fibroblast were detected in psoriasis model mouse samples (Fig. 5D). Taken together with fibronectin immunofluorescence study (Fig. 3D), production of fibronectin seems to be increased by the fibroblasts of psoriasis.

Figure 5.

The number of hemidesmosomes is not changed in psoriasis model mice. (A) By using TEM, the number of hemidesmosomes was not affected in psoriasis-like skin lesions compared with vehicle control. The arrow indicates lamina densa. (B) The thickness of lamina densa was significantly increased in mouse model of psoriasis. (Mean ± SEM, n=5, ***p<0.001.) (C) A few gaps of lamina densa in psoriasis-like skin lesions were seen. (D) Numerous string-like structures attached to dermal fibroblast were detected within the lesional skin samples of psoriasis model mouse. (Scale bars = 500 nm.) Abbreviations: TEM, transmission electron microscopy; N.S., not significant; NIH, National Institutes of Health; SEM = standard error of the mean.

Type IV Collagen Expression Is Significantly Upregulated Within the Lesional Skin of Psoriasis in Mice

Since the main component of lamina densa is considered to be type IV collagen,^40,41 we next investigated the expression of type IV collagen of psoriasis model mouse. As a result, type IV collagen expression within the BM was significantly increased in lesional skin of psoriasis compared with the control mice (Fig. 6A and B). Interestingly, there were a few gaps of type IV collagen within the BM (Fig. 6A).

Figure 6.

Type IV collagen expression is upregulated in psoriatic skin lesion in mice. (A, B) Immunofluorescence study of both vehicle-treated control and psoriatic skin samples. Compared with the vehicle-treated skin, the expression of type IV collagen of psoriasis-like skin lesions was significantly increased along the BM. There were a few gaps of type IV collagen within the BM (the white arrow). The yellow arrow indicates BM. (Mean ± SEM, n=5, ***p<0.001. Scale bars = 50 μm.) Abbreviations: BM, basement membrane; N.S., not significant; NIH, National Institutes of Health; SEM = standard error of the mean.

Laminin-511 Inhibits Apoptosis of HaCaT Cells

Human placental laminin-511/521 is reported to increase the human KCs number.⁴² To investigate the effect of laminin-511 but not laminin-521 on KC proliferation/apoptosis, we next performed HaCaT cells culture with various concentrations of recombinant laminin-511. HaCaT cells are immortalized human KCs, share several characteristics with psoriatic KCs, and are often used as a cellular model of psoriasis.^43–50

As a result, laminin-511 at 1 μg/ml significantly increased HaCaT cells proliferation compared with the control evaluated by Ki-67 immunofluorescence (Fig. 7A). This suggests that laminin-511 plays a role as a KC growth stimulator, which is similar to our previous findings by human HF organ culture.²⁸ Furthermore, laminin-511 treatment at 0.1 μg/ml and 10 μg/ml significantly decreased HaCaT cells apoptosis (assessed by cleaved caspase-3 immunofluorescence; Fig. 7B). As HaCaT cells are reported to constitutively express laminin-α5, β1, and γ1 chains,⁵¹ this suggests that laminin-511 may be important for KC survival and in the pathobiology of psoriasis.

Figure 7.

Laminin-511 stimulates keratinocytes proliferation and inhibits their apoptosis. (A) (Upper images) Representative images of Ki-67 immunofluorescence. Green indicates Ki-67 positive immunoreactivity. (Lower graph) Laminin-511 at 1 μg/ml significantly increased HaCaT cells proliferation compared with the control evaluated by Ki-67 immunofluorescence. (B) (Upper images) Representative images of cleaved caspase-3 immunofluorescence. Green indicates cleaved caspase-3 positive immunoreactivity. (Lower graph) Laminin-511 at 0.1 μg/ml and 10 μg/ml significantly decreased apoptosis assessed by cleaved caspase-3 immunofluorescence. (**p<0.01. ***p<0.001. One-way ANOVA, Bonferroni’s Comparison Test.)

Laminin-α5 Chain Gene Knockdown in HaCaT Cells Decreases Proliferation and Induces Apoptosis

As shown above, laminin-511 treatment did not only stimulate KCs proliferation but also inhibited their apoptosis (Fig. 7A and B). This suggested that laminin-511 plays important roles in maintaining KCs homeostasis.

Therefore, to next investigate the effect of laminin-511 blockade on epidermal KCs, we performed laminin-α5 gene knockdown in HaCaT cells using siRNA. Successful laminin-α5 gene knockdown was demonstrated by immunofluorescence microscopy, which showed significantly decreased laminin-α5 protein expression to control cells treated with scrambled siRNA (SCR; Fig. 8A).

Figure 8.

The gene knockdown of laminin-α5 chain of laminin-511 decreases keratinocytes proliferation and increases their apoptosis. (A) Successful laminin-α5 gene knockdown was assessed by laminin-α5 immunofluorescence. (B, C) Laminin-α5 gene knockdown significantly decreased HaCaT cell proliferation (evaluated by Ki-67 immunofluorescence), whereas it increased apoptosis (evaluated by cleaved caspase-3 immunofluorescence). (D, E) The decreased proliferation of HaCaT cells by laminin-α5 gene knockdown was recovered by laminin-511 treatment (at 1 μg/ml), whereas the significantly increased apoptosis by laminin-α5 gene knockdown was partially diminished by the co-administration of laminin-511. (*p<0.05. **p<0.01. ***p<0.001. One-way ANOVA, Bonferroni’s Comparison Test. Scale bars = 50 μm.) Abbreviations: TFE, transfection reagent; NIH, National Institutes of Health; SCR, scrambled siRNA.

Importantly, laminin-α5 gene knockdown in HaCaT cells significantly decreased their proliferation as measured by Ki-67 immunofluorescence (Fig. 8B), whereas it significantly increased HaCaT cell apoptosis (Fig. 8C).

Furthermore, additional HaCaT cell cultures showed that the decreased proliferation of HaCaT cells by laminin-α5 gene knockdown could be recovered by co-administration of laminin-511 (Fig. 8D). In addition, significantly increased apoptosis by laminin-α5 gene knockdown was partially diminished by co-administration of laminin-511 (Fig. 8E).

Taken together with the above findings in human and murine psoriatic skin, these functional cell culture experiments in a human KC cell line that shares some features with psoriatic epidermal KCs are consistent with the concept that laminin-511 may be important for maintaining KC hyperproliferation and reduced apoptosis in psoriatic epidermal lesions.

Discussion

In this study, we showed that (1) the expression of laminin-511 and -332 was significantly upregulated along the BM within the lesional skin of psoriasis vulgaris in human; (2) the expression of BM components, including laminin-α5, β1, γ1, laminin-332, β1 integrin and β4 integrin, as well as fibronectin, within the lesional skin of mouse model of psoriasis were also significantly increased along the BM by immunofluorescence study; (3) although the number of hemidesmosomes was not affected in psoriasis-like skin lesions compared with vehicle control, the thickness of lamina densa was significantly increased, and there were a few gaps detected in the lamina densa; (4) laminin-511 significantly increases surrogate “psoriatic” KCs,⁵⁰ HaCaT cells proliferation, and inhibits their apoptosis; (5) laminin-α5 chain gene knockdown in HaCaT cells decreases their proliferation and induces apoptosis; (6) laminin-511 treatment diminished the effect of laminin-α5 chain gene knockdown on HaCaT cells proliferation and apoptosis.

McFadden et al. hypothesized that basal KCs can interact with fibronectin via α5β1 integrin due to the disruption of laminins, and, therefore, the proliferation of these KCs may be stimulated.^{18,20–23,52} This seems to contradict our results on the expression of laminin-332 and -511. However, they focused on laminins composed of laminin α1 or α2 chains.^{18,20–23,52} In addition, in contrast to the concepts by McFadden et al.,^{18,20–23,52} Toti et al. reported that the expression of laminin-111 (composed of α1, β1, and γ1 chains) was normal, with intense and continuous reaction in human psoriatic skin.²³

Although both laminin α1 and α2 chains are expressed in skin,^53,54 main laminins within the skin are laminin-332 and -511.⁹ Our results showed that the expression of laminin-511 was significantly increased in lesional skin in mouse model of psoriasis (Fig. 2B–D) and of psoriasis patients (Fig. 1A and B). We also considered the possibility that the disruption of laminin-511 and -332 could be induced during the early phase of psoriasis. However, we could not find any obvious results that indicate the disruption of these laminins (day 0 to 2 after IMQ application; Fig. 4). It is still possible that the disruption of these laminins is induced during the very early phase after the IMQ application (e.g., 4 hr). This needs to be further investigated. In contrast to our findings, Fleischmajer et al. reported that the expression of laminin including laminin-α5, β1, and γ1 chains was reduced in psoriatic skin.¹⁵ It is very difficult to explain the discrepancy of laminin-511 expression pattern in skin lesion of psoriasis. However, Fleischmajer et al. included and evaluated the patients treated with ultraviolet B (47%), psolaren plus ultraviolet A (11%).¹⁵ It is possible that the treatment altered these laminin expressions. For instance, the reduced laminin expression (α2 chain) in psoriatic skin was reported to be recovered after the treatment by cyclosporine.²³ Furthermore, Rouabhia et al. reported that the ultraviolet (UV) irradiation on engineered human skin showed a complete absence of laminin deposition.⁵⁵ There is a possibility that the treatment for psoriasis, including UV irradiation, affects laminin expression.

Fleischmajer et al. also reported that there are gaps along the lamina densa of psoriatic skin detected by TEM.¹⁵ Similar phenomena has been reported by others.^56–58 Interestingly, Madalene et al. reported that basal KC herniation through the gap of lamina densa seems to correlate with disease activity.⁵⁸ Although we could not find obvious basal KC herniation, there are several gaps of lamina densa detected in psoriasis model mouse (Fig. 5C). Lamina densa is mainly composed of laminins and collagen type IV.^8,41 However, we could not detect any disruption of laminin-511 and -332. Taken together with the results of collagen type IV immunofluorescence study (Fig. 6A), the gaps along the lamina densa seem to be related to the disruption of collagen type IV. We also found that the thickness of lamina densa was significantly increased in psoriatic lesional skin in mice (Fig. 5A and B). This seems to be related to the increased expression of collagen type IV along the BM (Fig. 6A and B). It is possible that collagen type IV expression might be stimulated to compensate the disruption of its expression along the BM (Fig. 6A). Interestingly, laminin-332 is reported to accelerate the formation of lamina densa.⁵⁹ In addition, β3 chain short arm of laminin-332 is reported to induce laminin-511 matrix assembly.⁶⁰ The upregulated laminin-332 or -511 expression in psoriatic skin (Figs. 2B–D and 3B) could be related to the thickened lamina densa (Fig. 5A and B). Because the number of hemidesmosomes was not affected in psoriatic lesional skin in mice (Fig. 5A and B), the thickened lamina densa might be not only induced by upregulated collagen type IV, but also by the upregulated laminin-511 expression. It is possible that the upregulation of laminin-511 is induced by the disruption of collagen type IV to compensate the gaps of lamina densa. Further investigation on whether the upregulated laminin-511 expression is related to increased expression of β3 chain of laminin-332 or disruption of collagen type IV would be needed as a future study.

Interestingly, psoriasis shares many features, including antimicrobial peptides expression and several KC markers expression, with wound healing.⁶¹ Importantly, laminin-511/521 is shown to stimulate KC migration in an in vitro wound healing assay,⁴² and this suggests that laminin-511/521 may promote wound healing.⁶² It is also known that both fibronectin and laminin-332 are upregulated during wounding.⁶³ This “psoriasis-wound healing” concept supports our findings of upregulated laminin-332 and -511 expression in psoriatic skin both in human and mice (Figs. 1A and B, 2B–D and 3B).

Our HaCaT cell culture showed that laminin-511 blockade by laminin-α5 chain gene knockdown decreased the proliferation of normal HaCaT cells (Fig. 8B) as well as stimulated HaCaT cells by laminin-511 treatment (Fig. 8D). Taken together with our immunofluorescence results of laminin-511 (Fig. 2B–D), agents that may inhibit the effect of laminin-511 could be useful for the treatment for psoriasis.

For instance, laminin-511 has epidermal growth factor (EGF)-like repeats within the α5 chain.²⁶ The EGF-like repeats of laminin and tenascin-C are reported to directly trigger epidermal growth factor receptor (EGFR) signaling.⁶⁴ There is an interesting case report on EGFR and psoriasis. A patient with advanced colon cancer and concomitant long-standing psoriasis vulgaris who received anti-EGFR antibody monotherapy as a third-line treatment for metastatic disease showed dramatical improvement of psoriatic skin lesions 1 week after the initiation of treatment.⁶⁵ It is possible that anti-EGFR antibody could not only block the binding of endogenous EGF to its receptor but also reduce the effect of EGF-like repeats of laminin-511. This may suggest that the blockade of laminin-511 can be considered as an optional antipsoriasis therapy.

In conclusion, the phenomenological observations reported here raise the question whether laminin-511-controlled KC growth/death may be a previously overlooked player in the pathogenesis of psoriatic epidermal lesions.

Footnotes

Acknowledgements

The excellent technical support of Ms Ayano Yonamine is gratefully appreciated. We thank Dr Jeffrey Miner for providing an antibody against murine laminin α3 chain. We also thank Prof Jonathan C.R. Jones for J18.

Competing Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Author Contributions

AN, KS, MY, and YM performed all of the experiments. AN, KS, DT, and RP assisted in experimental design, data interpretation, and manuscript writing. SS and AM provided human skin samples and assisted in manuscript writing. All authors have read and approved the manuscript as submitted.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Ethics Approval

This study was approved by the ethics committee of Osaka City University Graduate School of Medicine, Osaka, Japan (2016-3490).

References

Raj

Brash

Grossman

Keratinocyte apoptosis in epidermal development and disease. J Invest Dermatol. 2006;126(2):243–57.

Moorchung

Kulaar

Chatterjee

Vasudevan

Tripathi

Dutta

Role of NF-κB in the pathogenesis of psoriasis elucidated by its staining in skin biopsy specimens. Int J Dermatol. 2014;53(5):570–4.

Boehncke

Schon

MP.

Psoriasis. Lancet.2015;386(9997):983–94.

Hawkes

Chan

Krueger

JG.

Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol. 2017;140(3):645–53.

Feldman

Goffe

Rice

Mitchell

Kaur

Robertson

Sierka

Bourret

Evans

Gottlieb

The challenge of managing psoriasis: unmet medical needs and stakeholder perspectives. Am Health Drug Benefits. 2016;9(9):504–13.

Ronholt

Iversen

Old and new biological therapies for psoriasis. Int J Mol Sci. 2017;18(11):E2297.

Charonis

Sidderaki

Kaltezioti

Alberti

Vlahakos

Tsilibary

Basement membrane peptides: functional considerations and biomedical applications in autoimmunity. Curr Med Chem. 2005;12(13):1495–502.

Breitkreutz

Koxholt

Thiemann

Nischt

Skin basement membrane: the foundation of epidermal integrity—BM functions and diverse roles of bridging molecules nidogen and perlecan. Biomed Res Int. 2013;2013:179784.

Sugawara

Tsuruta

Imanishi

Jones

Kobayashi

Laminin-332 and -511 in skin. Exp Dermatol. 2008;17(6):473–80.

10.

Amano

Characterization and mechanisms of photoageing-related changes in skin. Damages of basement membrane and dermal structures. Exp Dermatol. 2016;Suppl 3:14–9.

11.

Tsuruta

Kobayashi

Imanishi

Sugawara

Ishii

Jones

JC.

Laminin-332-integrin interaction: a target for cancer therapy?

Curr Med Chem. 2008;15(20):1968–75.

12.

Watt

Fujiwara

Cell-extracellular matrix interactions in normal and diseased skin. Cold Spring Harb Perspect Biol. 2011;3(4):a005124.

13.

Miner

Yurchenco

PD.

Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol. 2004;20:255–84.

14.

Kruegel

Miosge

Basement membrane components are key players in specialized extracellular matrices. Cell Mol Life Sci. 2010;67(17):2879–95.

15.

Fleischmajer

Kuroda

Hazan

Gordon

Lebwohl

Sapadin

Unda

Iehara

Yamada

Basement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2. J Invest Dermatol. 2000;115(5):771–7.

16.

Seyger

van den Born

Schalkwijk

van de Kerkhof

de Jong

EM.

Altered distribution of heparan sulfate proteoglycans in psoriasis. Acta Derm Venereol. 1997;77(2):105–9.

17.

Noah

Handorf

Skinner

Jr Mandrell

Rosenberg

EW.

Skin basement membrane zone: a depository for circulating microbial antigen evoking psoriasis and autoimmunity. Skinmed. 2006;5(2):72–9.

18.

McFadden

Kimber

A review on the potential role of basement membrane laminin in the pathogenesis of psoriasis. Scand J Immunol. 2016;83(1):3–9.

19.

McFadden

Baker

Powels

Fry

Psoriasis and extra domain A fibronectin loops. Br J Dermatol. 2010;163(1):5–11.

20.

McFadden

Fry

Powels

Kimber

Concepts in psoriasis: psoriasis and the extracellular matrix. Br J Dermatol. 2012;167(5):980–6.

21.

Mondello

Magaudda

Pergolizzi

Santoro

Vaccaro

Califano

Cannavo

Guarneri

Behaviour of laminin 1 and type IV collagen in uninvolved psoriatic skin. Immunohistochemical study using confocal laser scanning microscopy. Arch Dermatol Res. 1996;288(9):527–31.

22.

Vaccaro

Magaudda

Cutroneo

Trimarchi

Barbuzza

Guarneri

Changes in the distribution of laminin α1 chain in psoriatic skin: immunohistochemical study using confocal laser scanning microscopy. Br J Dermatol. 2002;146(3):392–8.

23.

Toti

Pellegrino

Villanova

Flori

Miracco

Bartolommei

Andreassi

Altered expression of the α2 laminin chain in psoriatic skin: the effect of treatment with cyclosporine. Br J Dermatol. 1998;139(3):375–9.

24.

Sawan

Descamps

Scalp psoriasis: a paradigm of “switch-on” mechanism to anagen hair growth?

Arch Dermatol. 2008;144(8):1064–6.

25.

Tzu

Chen

Zhang

Nguyen

Gao

Bradley

Keene

Oro

Miner

Marinkovich

MP.

Laminin-10 is crucial for hair morphogenesis. EMBO J. 2003;22(10):2400–10.

26.

Gao

DeRouen

Chen

Nguyen

Ido

Harada

Sekiguchi

Morgan

Miner

Oro

Marinkovich

MP.

Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis. Genes Dev. 2008;22(15):2111–24.

27.

Imanishi

Tsuruta

Tateishi

Sugawara

Kobayashi

Ishii

Kishi

Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis. Med Mol Morphol. 2014;47(1):38–42.

28.

Sugawara

Tsuruta

Kobayashi

Ikeda

Hopkinson

Jones

Ishii

Spatial and temporal control of laminin-332 (5) and -511 (10) expression during induction of anagen hair growth. J Histochem Cytochem. 2007;55(1):43–55.

29.

Tateishi

Tsuruta

Sugawara

Yoshizato

Imanishi

Nishida

Ishii

Kobayashi

Spatial and temporal control of laminin-511 and -332 expressions during catagen. J Dermatol Sci. 2010;58(1):55–63.

30.

Imanishi

Tsuruta

Tateishi

Sugawara

Paus

Tsuji

Ishii

Ikeda

Kunimoto

Nakajima

Jones

Kobayashi

Laminin-511, inducer of hair growth, is down-regulated and its suppressor in hair growth, laminin-332 up-regulated in chemotherapy-induced alopecia. J Dermatol Sci. 2010;58(1):43–54.

31.

Van de Kerkhof

Van Erp

PE.

The role of epidermal proliferation in the pathogenesis of psoriasis. Skin Pharmacol. 1996;9(6):343–54.

32.

Joffre

Hau

Zeboudj

Laurans

Battistella

Boufenzer

Masson

Le Buanec

Cochaud

Bagot

Bensussan

Gibot

Bouaziz

Ait-Oufella

Trem-1 is not crucial in psoriasiform imiquimod-induced skin inflammation in mice. Exp Dermatol. 2016;25(5):400–2.

33.

Stjernholm

Ommen

Langkilde

Johansen

Iversen

Rosada

Stenderup

Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes. Exp Dermatol. 2017;26(4):338–45.

34.

van der Fits

Mourits

Voerman

Kant

Boon

Laman

Cornelissen

Mus

Florencia

Prens

Lubberts

Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol. 2009;182(9):5836–45.

35.

Hohenester

Yurchenco

PD.

Laminins in basement membrane assembly. Cell Adh Migr. 2013;7(1):56–63.

36.

Guban

Vas

Balog

Manczinger

Bebes

Groma

Szell

Kemeny

Bata-Csorgo

Abnormal regulation of fibronectin production by fibroblasts in psoriasis. Br J Dermatol. 2016;174(3):533–41.

37.

Szlavicz

Szabo

Groma

Bata-Csorgo

Pagani

Kemeny

Szell

Splicing factors differentially expressed in psoriasis alter mRNA maturation of disease-associated EDA+ fibronectin. Mol Cell Biochem. 2017;436(1–2):189–99.

38.

Pongpairoj

McFadden

JP.

Psoriasis, extradomain A+ fibronectin and the extracellular matrix. Br J Dermatol. 2016;174(3):486.

39.

Walko

Castanon

Wiche

Molecular architecture and function of the hemidesmosome. Cell Tissue Res. 2015;360(3):529–44.

40.

Gay

Kresina

Gay

Miller

Montes

LF.

Immunohistochemical demonstration of basement membrane collagen in normal human skin and in psoriasis. J Cutan Pathol. 1979;6(2):91–5.

41.

Behrens

Villone

Koch

Brunner

Sorokin

Robenek

Bruckner-Tuderman

Bruckner

Hansen

The epidermal basement membrane is a composite of separate laminin- or collagen IV-containing networks connected by aggregated perlecan, but not by nidogens. J Biol Chem. 2012;287(22):18700–9.

42.

Pouliot

Saunders

Kaur

Laminin 10/11: an alternative adhesive ligand for epidermal keratinocytes with a functional role in promoting proliferation and migration. Exp Dermatol. 2002;11(5):387–97.

43.

Soboleva

Zolotarenko

Sobolev

Bruskin

Piruzian

Mezentsev

AV.

Genetically predetermined limitation in the use of HaCaT cells that affects their ability to serve as an experimental model of psoriasis. Genetika. 2014;50(10):1222–31.

44.

Balato

Lembo

Mattii

Schiattarella

Marino

De Paulis

Balato

Ayala

IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation. Exp Dermatol. 2012;21(11):892–4.

45.

Farkas

Kemeny

Szony

Bata-Csorgo

Pivarcsi

Kiss

Szell

Koreck

Dobozy

Dithranol upregulates IL-10 receptors on the cultured human keratinocyte cell line HaCaT. Inflamm Res. 2001;50(1):44–9.

46.

George

Anderson

Cunningham

Donaldson

Groundwater

PW.

Evaluation of a range of anti-proliferative assays for the preclinical screening of anti-psoriatic drugs: a comparison of colorimetric and fluorimetric assays with the thymidine incorporation assay. Assay Drug Dev Technol. 2010;8(3):389–400.

47.

Kim

Byamba

Lee

MG.

Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: possible relevance to psoriasis treatment. Exp Dermatol. 2011;20(10):855–7.

48.

Ronpirin

Tencomnao

Effects of the antipsoriatic drug dithranol on E2A and caspase-9 gene expression in vitro. Genet Mol Res. 2012;11(1):412–20.

49.

Saelee

Thongrakard

Tencomnao

Effects of Thai medicinal herb extracts with anti-psoriatic activity on the expression on NF-κB signaling biomarkers in HaCaT keratinocytes. Molecules. 2011;16(5):3908–32.

50.

Ramot

Sugawara

Zakany

Toth

Biro

Paus

A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ. Peer J. 2013;1:e40.

51.

Kikkawa

Takaki

Matsuda

Okabe

Taniguchi

Oomachi

Samejima

Katagiri

Hozumi

Nomizu

The influence of Tribenoside on expression and deposition of epidermal laminins in HaCaT cells. Biol Pharm Bull. 2010;33(2):307–10.

52.

Ohata

Ishii

Koga

Fukuda

Tateishi

Tsuruta

Furumura

Hashimoto

Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: a series of 145 cases. J Am Acad Dermatol. 2015;73(1):50–5.

53.

Sanes

Enqvall

Butkowski

Hunter

DD.

Molecular heterogeneity of basal laminae: isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J Cell Biol. 1990;111(4):1685–99.

54.

Squarzoni

Villanova

Sabatelli

Malandrini

Toti

Pini

Merlini

Guazzi

Maraldi

NM.

Intracellular detection of laminin α₂ chain in skin by electron microscopy immunocytochemistry: comparison between normal and laminin α₂ chain deficient subjects. Neuromuscul Disord. 1997;7(2):91–8.

55.

Rouabhia

Mitchell

Rhainds

Claveau

Drouin

A physical sunscreen protects engineered human skin against artificial solar ultraviolet radiation-induced tissue and DNA damage. Photochem Photobiol Sci. 2002;1(7):471–7.

56.

Brody

Dermal and epidermal involvement in the evolution of acute eruptive guttate psoriasis vulgaris. J Invest Dermatol. 1984;82(5):465–70.

57.

Cox

AJ.

The dermal-epidermal junction in psoriasis. J Invest Dermatol. 1969;53(6):428–35.

58.

Madalene

Heng

Kloss

Kuehn

Chase

DG.

Significance and pathogenesis of basal keratinocyte herniations in psoriasis. J Invest Dermatol. 1986;87(3):362–659.

59.

Tsunenaga

Adachi

Amano

Burgeson

Nishiyama

Laminin 5 can promote assembly of the lamina densa in the skin equivalent model. Matrix Biol. 1998;17(8–9):603–13.

60.

Nakashima

Kariya

Miyazaki

The beta3 chain short arm of laminin-332 (laminin-5) induces matrix assembly and cell adhesion activity of laminin-511 (laminin-10). J Cell Biochem. 2007;100(3):545–56.

61.

Morhenn

Nelson

Gruol

DL.

The rate of wound healing is increased in psoriasis. J Dermatol Sci. 2013;72(2):87–92.

62.

Iorio

Troughton

Hamill

KJ.

Laminins: roles and utility in wound repair. Adv Wound Care (New Rochelle). 2015;4(4):250–63.

63.

Chen

Tjin

Chua

AWC

Lee

Tay

Fong

Probing the role of integrins in keratinocyte migration using bioengineered extracellular matrix mimics. ACS Appl Mater Interfaces. 2017;9(42):36483–92.

64.

Swindle

Tran

Johnson

Banerjee

Mayes

Griffith

Wells

Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J Cell Biol. 2001;154(2):459–68.

65.

Okamoto

Maeda

Shiga

Dabanaka

Hanazaki

Kobayashi

Cetuximab and panitumumab in a patient with colon cancer and concomitant chronic skin disease: a potential beneficial effect on psoriasis vulgaris. World J Gastroenterol. 2015;21(12):3746–9.

Re-investigating the Basement Membrane Zone of Psoriatic Epidermal Lesions: Is Laminin-511 a New Player in Psoriasis Pathogenesis?

Abstract

Keywords

Introduction

Materials and Methods

Antibodies

Mice and Treatment

Human Samples

Histopathology and Immunohistochemistry (IHC)

Transmission Electron Microscopy (TEM)

HaCaT Cells Culture and IHC

Measuring Fluorescence Intensity by Using NIH ImageJ

Statistical Analysis

Results

The Expression of Laminin-332 and -511 Is Significantly Upregulated in Psoriatic Lesions

The Expression of Laminin-332 and -511 Is Also Upregulated Within the Lesional Skin of Psoriasis in Mice

Ultrastructural Evaluation by TEM

Type IV Collagen Expression Is Significantly Upregulated Within the Lesional Skin of Psoriasis in Mice

Laminin-511 Inhibits Apoptosis of HaCaT Cells

Laminin-α5 Chain Gene Knockdown in HaCaT Cells Decreases Proliferation and Induces Apoptosis

Discussion

Footnotes

Acknowledgements

Competing Interests

Author Contributions

Funding

Ethics Approval

References